Enzyme Replacement Therapy During Pregnancy in Fabry Patients: Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating Pregnancy

Fabry disease (FD) is an X-linked, lysosomal storage disease. Mutations in the gene coding for alpha-galactosidase A lead to globotriaosylceramide (Gb-3) accumulation in lysosomes and in placenta and umbilical cord. Impact of FD and treatment with enzyme replacement (ERT) on foetal development is un...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JIMD Rep
Main Authors: Madsen, Christoffer V., Christensen, Erik Ilsø, Nielsen, Rikke, Mogensen, Helle, Rasmussen, Åse K., Feldt-Rasmussen, Ulla
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323029/
https://ncbi.nlm.nih.gov/pubmed/30117110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2018_129
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares